Publication | Closed Access

An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial

ThrombosisPivotal TrialIschemic StrokeMedicineInjectable ImplantCerebrovascular DiseaseSphenopalatine GanglionRehabilitationNeurologyBrain InjuryCerebrovascular InterventionCerebral Blood FlowStrokeIschemic Syndrome